The diagnosis and management of acne

Pediatric Annals

Volumn 29, Issue 1, 2000, Pages 17-24

  Sidbury, Robert ^a   Paller, Amy S ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; DOXYCYCLINE; MINOCYCLINE; RETINOIC ACID; RETINOL DERIVATIVE; SALICYLIC ACID DERIVATIVE; TAZAROTENE; TETRACYCLINE;

ACNE; ANTIBIOTIC THERAPY; COMEDO; GASTROINTESTINAL DISEASE; HUMAN; PATHOPHYSIOLOGY; REVIEW; SKIN INFLAMMATION; STEVENS JOHNSON SYNDROME; VESTIBULAR DISORDER;

EID: 0033985652     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20000101-06     Document Type: Review

References (35)

1. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998;39:S34-S37.
2. Jansen T, Burgdorf W, Plewig G. Pathogenesis and treatment of acne in childhood. Pediatr Dermatol. 1997;14:17-21.
3. Bergfeld W. The evaluation and management of acne: economic considerations. J Am Acad Dermatol. 1995;32:S52-S56.
4. Niemeier V, Kupfer J, Demmelbauer-Ebner M, et al. Coping with acne vulgaris: evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology. 1998;196:108-115.
5. Koo J. The psychosocial impact of acne: patient's perceptions. J Am Acad Dermatol. 1995;32:S26-S30.
6. Brown SK, Shalita AR. Acne vulgaris. Lancet. 1998; 351:1871-1876.
7. Morello AM, Downing DT, Strauss JS. Octadecanoic acids in the skin surface: lipids of acne patients and normal subjects. J Invest Dermatol. 1976;66:319-322.
8. Strauss JS, Kligman AM. The pathologic dynamics of acne vulgaris. Arch Dermatol. 1960;82:779-790.
9. Sizonenko PC, Paumier L. Hormonal changes in puberty: III. Correlation of plasma dehydroepiandrosterone, testosterone, FSH, and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison's disease or hypogonadism or with premature or late adrenarche. J Clin Endocrinol Metab. 1975;41:894-904.
10. Rothman KF, Lucky AW. Acne vulgaris. Adv Dermatol. 1993;8:347-374.
11. Leyden JJ. Therapy for acne vulgaris. N Engl J Med. 1997; 336:1156-1162.
12. Pochi PE, Strauss JS. Endocrinologic control of the development and activity of the human sebaceous gland. J Invest Dermatol. 1964;43:383-388.
13. Lucky AW, Biro FM, Simbarti LA, et al. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr. 1997;130:30-39.
14. Puhvel SM, Sakamoto M. The chemoattractant properties of comedonal components. J Invest Dermatol. 1978;71:324-329.
15. Shalita AR, Lee WL. Inflammatory acne. Dermatol Clin. 1983;1:361-364.
16. Leyden JJ, Shalita AR. Rational therapies for acne vulgaris: an update on topical treatment. J Am Acad Dermatol. 1986;15:907-914.
17. Shalita AR, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol. 1996;34:482-485.
18. Shalita AR, Chalker DK, Griffith RF, et al. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study. Cutis. 1999;63:349-354.
19. Leyden JJ. Topical treatment of acne vulgaris: retinoids and cutaneous irritation. J Am Acad Dermatol. 1998;38:S1-S4.
20. Shalita AR. Treatment of mild and moderate acne vulgaris with salicylic acid in an alcohol-detergent vehicle. Cutis. 1981;28:556-558, 561.
21. Cunliffe WJ, Holland KT. The effect of benzoyl peroxide on acne. Acta Dermatol Venereol (Stockh). 1980;61:267-269.
22. Chalker DK, Shalita AR, Smith JG, et al. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983;9:933-936.
23. Cunliffe WJ, Holland KT. Clinical and laboratory studies on treatment with 20% azelaic acid cream for acne. Acta Dermatol Venereol (Stockh). 1989;133(suppl):31-34.
24. Helms SE, Bredle DL, Zajic J, et al. Oral contraceptive failure rates and oral antibiotics. J Am Acad Dermatol. 1997;36:705-710.
25. Sturkenboom MCJM, Meier CR, Jick H, et al. Minocycline and lupuslike syndrome in acne patients. Arch Intern Med. 1999;159:493-497.
26. Eady EA, Cove JH, Holland KT, et al. Erythromycin-resistant proprionibacteria in antibiotic treated patients: association with treatment failure. Br J Dermatol. 1989;121:51-57.
27. Neubert U, Jansen T, Plewig G. Bacteriologic and immunologic aspects of gram-negative folliculitis: a study of 46 patients. M J Dermatol. 1999;38:270-274.
28. Bolognia JL, Edelson RL. Spread of antibiotic-resistant bacteria from acne patients to personal contacts: a problem beyond the skin? Lancet. 1997;350:972-973.
29. Imperato-McGinley J, Gautier T, Cal LQ, et al. The androgen control of sebum production: studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab. 1993;76:524-528.
30. Shaw JC. Anti-androgen and hormonal treatment of acne. Dermatol Clin. 1996;14:803-811.
31. Lucky AW, Henderson TA, Olson WH, et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997;37:746-754.
32. Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy of acne: results of a multicenter dose-response study. J Am Acad Dermatol. 1984;10:490-496.
33. Bershad S, Rubenstein A, Paterniti JR Jr, et al. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Eng J Med. 1985;313:981.
34. Koo JY, Smith LL. Psychologic aspects of acne. Pediatr Dermatol. 1991;8:185-188.
35. Mengesha YM, Hansen RC. Toddler-age nodulocystic acne. J Pediatr 1999;134:644-648.